Combined Targeting of Glioblastoma Stem-Like Cells by Neutralizing RNA-Bio-Drugs for STAT3
Carla Lucia Esposito(Institute for Experimental Endocrinology and Oncology), Vittorio de Franciscis(Institute for Experimental Endocrinology and Oncology)
Cited by 23
Related Papers
Frontiers in Drug Design and Discovery
|Unknown|2006|49
STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts
|Molecular Therapy — Nucleic Acids|2023|13